Cargando…

Update on Procalcitonin Measurements

Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock. At the same time, PCT has also been used to guide antibiotic therapy. This review outlines the main indications for PCT measurement and points out possible pitfalls. The classic indications for PC...

Descripción completa

Detalles Bibliográficos
Autor principal: Meisner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071182/
https://www.ncbi.nlm.nih.gov/pubmed/24982830
http://dx.doi.org/10.3343/alm.2014.34.4.263
_version_ 1782322782569234432
author Meisner, Michael
author_facet Meisner, Michael
author_sort Meisner, Michael
collection PubMed
description Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock. At the same time, PCT has also been used to guide antibiotic therapy. This review outlines the main indications for PCT measurement and points out possible pitfalls. The classic indications for PCT measurement are: (i) confirmation or exclusion of diagnosis of sepsis, severe sepsis, or septic shock, (ii) severity assessment and follow up of systemic inflammation mainly induced by microbial infection, and (iii) individual, patient adapted guide of antibiotic therapy and focus treatment. Using serially monitored PCT levels, the duration and need of antibiotic therapy can be better adapted to the individual requirements of the patient. This individualized approach has been evaluated in various studies, and it is recommended to be a part of an antibiotic stewardship program.
format Online
Article
Text
id pubmed-4071182
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Society for Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-40711822014-07-01 Update on Procalcitonin Measurements Meisner, Michael Ann Lab Med Review Article Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock. At the same time, PCT has also been used to guide antibiotic therapy. This review outlines the main indications for PCT measurement and points out possible pitfalls. The classic indications for PCT measurement are: (i) confirmation or exclusion of diagnosis of sepsis, severe sepsis, or septic shock, (ii) severity assessment and follow up of systemic inflammation mainly induced by microbial infection, and (iii) individual, patient adapted guide of antibiotic therapy and focus treatment. Using serially monitored PCT levels, the duration and need of antibiotic therapy can be better adapted to the individual requirements of the patient. This individualized approach has been evaluated in various studies, and it is recommended to be a part of an antibiotic stewardship program. The Korean Society for Laboratory Medicine 2014-07 2014-06-19 /pmc/articles/PMC4071182/ /pubmed/24982830 http://dx.doi.org/10.3343/alm.2014.34.4.263 Text en © The Korean Society for Laboratory Medicine. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Meisner, Michael
Update on Procalcitonin Measurements
title Update on Procalcitonin Measurements
title_full Update on Procalcitonin Measurements
title_fullStr Update on Procalcitonin Measurements
title_full_unstemmed Update on Procalcitonin Measurements
title_short Update on Procalcitonin Measurements
title_sort update on procalcitonin measurements
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071182/
https://www.ncbi.nlm.nih.gov/pubmed/24982830
http://dx.doi.org/10.3343/alm.2014.34.4.263
work_keys_str_mv AT meisnermichael updateonprocalcitoninmeasurements